Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

28.55

-0.51 (-1.75%)

At close: Nov 5, 2026, 4:00 PM EST

29.56

+1.01 (3.54%)

After-hours: Nov 5, 2026, 7:30 PM EST

Viridian Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	26.31	70.85	0.3	0.31	1.77	2.96
Revenue Growth	-62.83%	23359.93%	-3.82%	-82.28%	-40.20%	182.19%
Cost of Revenue	310.04	338.93	238.25	159.77	100.89	56.89
Gross Profit	-283.73	-268.08	-237.95	-159.45	-99.12	-53.92
Selling, General & Admin	184.94	95.32	61.08	95	35.18	25.81
Operating Expenses	184.94	95.32	61.08	95	35.18	25.81
Operating Income	-468.66	-363.4	-299.04	-254.45	-134.3	-79.73
Interest Expense	-24.32	-4.95	-2.2	-1.33	-0.49	-0
Interest & Investment Income	33.69	27.4	31.6	18.24	4.92	0.32
Other Non Operating Income (Expenses)	5.71	-1.66	-0.31	-0.19	-	-
EBT Excluding Unusual Items	-453.58	-342.6	-269.95	-237.73	-129.87	-79.41
Pretax Income	-453.58	-342.6	-269.95	-237.73	-129.87	-79.41
Net Income	-453.58	-342.6	-269.95	-237.73	-129.87	-79.41
Preferred Dividends & Other Adjustments	-55.98	-60.67	-61.39	-62.73	-42.83	-
Net Income to Common	-397.6	-281.93	-208.56	-175.01	-87.04	-79.41
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	105	85	68	45	32	12
Shares Outstanding (Diluted)	105	85	68	45	32	12
Shares Change	28.70%	24.92%	51.68%	39.48%	169.22%	235.07%
EPS (Basic)	-3.80	-3.32	-3.07	-3.91	-2.71	-6.66
EPS (Diluted)	-3.80	-3.32	-3.07	-3.91	-2.71	-6.66
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-343.44	-276.89	-232.83	-185.07	-94.64	-54.92
Free Cash Flow Per Share	-3.29	-3.27	-3.43	-4.13	-2.95	-4.61
Operating Margin	-1781.38%	-512.91%	-99018.21%	-81035.03%	-7579.23%	-2690.79%
Profit Margin	-1511.27%	-397.93%	-69059.60%	-55734.71%	-4912.13%	-2680.15%
Free Cash Flow Margin	-1305.42%	-390.81%	-77096.03%	-58938.85%	-5340.58%	-1853.49%
EBITDA	-467.96	-362.94	-298.5	-253.93	-134.05	-79.61
D&A For EBITDA	0.7	0.46	0.54	0.52	0.26	0.12
EBIT	-468.66	-363.4	-299.04	-254.45	-134.3	-79.73
Revenue as Reported	26.31	70.85	0.3	0.31	-	-

SEC Filings: 10-K · 10-Q